On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds
…, SSF Leung, AS Kalgutkar, JN Bauman… - Nature chemical …, 2011 - nature.com
Backbone N-methylation is common among peptide natural products and has a substantial
impact on both the physical properties and the conformational states of cyclic peptides. …
impact on both the physical properties and the conformational states of cyclic peptides. …
Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors
RL Walsky, JN Bauman, K Bourcier, G Giddens… - Drug Metabolism and …, 2012 - ASPET
The measurement of the effect of new chemical entities on human UDP-glucuronosyltransferase
(UGT) marker activities using in vitro experimentation represents an important …
(UGT) marker activities using in vitro experimentation represents an important …
Kinetics of Acetaminophen Glucuronidation by UDP-Glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential Implications in Acetaminophen− Induced …
AE Mutlib, TC Goosen, JN Bauman… - Chemical research in …, 2006 - ACS Publications
The importance of uridine 5‘-diphosphate-glucuronosyltranferases (UGT) 2B15 and other
UGT enzymes (1A1, 1A6, and 1A9) in glucuronidating acetaminophen (APAP) is demonstrated…
UGT enzymes (1A1, 1A6, and 1A9) in glucuronidating acetaminophen (APAP) is demonstrated…
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug
JN Bauman, KS Frederick, A Sawant, RL Walsky… - Drug metabolism and …, 2008 - ASPET
In vitro metabolism/bioactivation of structurally related central nervous system agents
nefazodone (hepatotoxin) and aripiprazole (nonhepatotoxin) were undertaken in human liver …
nefazodone (hepatotoxin) and aripiprazole (nonhepatotoxin) were undertaken in human liver …
Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies
GS Walker, JN Bauman, TF Ryder, EB Smith… - Drug Metabolism and …, 2014 - ASPET
The contribution of drug metabolites to the pharmacologic and toxicologic activity of a drug
can be important; however, for a variety of reasons metabolites can frequently be difficult to …
can be important; however, for a variety of reasons metabolites can frequently be difficult to …
The pharmacokinetics, metabolism, and clearance mechanisms of abrocitinib, a selective Janus kinase inhibitor, in humans
JN Bauman, AC Doran, A King-Ahmad… - Drug Metabolism and …, 2022 - ASPET
Abrocitinib is an oral once-daily Janus kinase 1 selective inhibitor being developed for the
treatment of moderate-to-severe atopic dermatitis. This study examined the disposition of …
treatment of moderate-to-severe atopic dermatitis. This study examined the disposition of …
Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid
TC Goosen, JN Bauman, JA Davis, C Yu, SI Hurst… - Drug metabolism and …, 2007 - ASPET
Gemfibrozil coadministration generally results in plasma statin area under the curve (AUC)
increases, ranging from moderate (2- to 3-fold) with simvastatin, lovastatin, and pravastatin to …
increases, ranging from moderate (2- to 3-fold) with simvastatin, lovastatin, and pravastatin to …
Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure–activity relationships and strategies for the elimination of reactive …
DP Walker, FC Bi, AS Kalgutkar, JN Bauman… - Bioorganic & medicinal …, 2008 - Elsevier
The synthesis and SAR for a series of diaminopyrimidines as PYK2 inhibitors are described.
Using a combination of library and traditional medicinal chemistry techniques, a FAK-…
Using a combination of library and traditional medicinal chemistry techniques, a FAK-…
Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes
VC Peterkin, JN Bauman, TC Goosen… - British journal of …, 2007 - Wiley Online Library
… The samples were then centrifuged at 14 000 rpm (15 000 g) for 10 min, supernatants
removed, mixtures dried under N 2 and reconstituted in mobile phase consisting of 84% 20 mm …
removed, mixtures dried under N 2 and reconstituted in mobile phase consisting of 84% 20 mm …
In vitro kinetic characterization of axitinib metabolism
…, TC Goosen, E Tseng, J Lin, JN Bauman… - Drug Metabolism and …, 2016 - ASPET
N-Methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide (axitinib) is an
oral inhibitor of vascular endothelial growth factor receptors 1–3, which is approved for the …
oral inhibitor of vascular endothelial growth factor receptors 1–3, which is approved for the …